Conduit Other Current Liab from 2010 to 2025

CDTTW Stock   0.01  0  10.00%   
Conduit Pharmaceuticals Other Current Liabilities yearly trend continues to be fairly stable with very little volatility. Other Current Liabilities will likely drop to about 513.9 K in 2025. During the period from 2010 to 2025, Conduit Pharmaceuticals Other Current Liabilities regression line of quarterly data had mean square error of 485.9 B and geometric mean of  1,765,653. View All Fundamentals
 
Other Current Liabilities  
First Reported
2010-12-31
Previous Quarter
540.9 K
Current Value
513.9 K
Quarterly Volatility
775.7 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Conduit Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Conduit Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 143.6 K, Selling General Administrative of 4.1 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Conduit financial statements analysis is a perfect complement when working with Conduit Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Conduit Pharmaceuticals Correlation against competitors.
For more information on how to buy Conduit Stock please use our How to Invest in Conduit Pharmaceuticals guide.

Latest Conduit Pharmaceuticals' Other Current Liab Growth Pattern

Below is the plot of the Other Current Liab of Conduit Pharmaceuticals over the last few years. It is Conduit Pharmaceuticals' Other Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Conduit Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Other Current Liab10 Years Trend
Slightly volatile
   Other Current Liab   
       Timeline  

Conduit Other Current Liab Regression Statistics

Arithmetic Mean1,994,618
Geometric Mean1,765,653
Coefficient Of Variation38.89
Mean Deviation541,012
Median2,235,000
Standard Deviation775,684
Sample Variance601.7B
Range2.9M
R-Value(0.50)
Mean Square Error485.9B
R-Squared0.25
Significance0.05
Slope(80,862)
Total Sum of Squares9T

Conduit Other Current Liab History

2025513.9 K
2024540.9 K
2023601 K
20223.4 M

About Conduit Pharmaceuticals Financial Statements

Conduit Pharmaceuticals investors use historical fundamental indicators, such as Conduit Pharmaceuticals' Other Current Liab, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Conduit Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Current Liabilities540.9 K513.9 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Conduit Stock Analysis

When running Conduit Pharmaceuticals' price analysis, check to measure Conduit Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Conduit Pharmaceuticals is operating at the current time. Most of Conduit Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Conduit Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Conduit Pharmaceuticals' price. Additionally, you may evaluate how the addition of Conduit Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Trending Assets

DEO
Diageo PLC ADR
122.20  1.50  1.24 
RDNT
RadNet Inc
67.64  0.47  0.70 
CASBF
CanSino Biologics
3.37  0.00  0.00 
COCO
Vita Coco
37.89  0.07  0.19